Pivotal Phase 2 trial of RP-A501 for Danon disease to resume in 1H 2026KRESLADI™ for severe LAD-I on track for March 28, 2026 ...
In post-acute care, Medicare is not an abstract federal program. It is Mrs. Thompson’s therapy after a hip fracture. It is Mr. Alvarez’s swallow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results